152 related articles for article (PubMed ID: 1282147)
1. Tattooing as a risk of hepatitis C virus infection.
Ko YC; Ho MS; Chiang TA; Chang SJ; Chang PY
J Med Virol; 1992 Dec; 38(4):288-91. PubMed ID: 1282147
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus infection as a risk factor for non-alcoholic liver cirrhosis in Taiwan.
Tsai JF; Chang WY; Jeng JE; Ho MS; Wang LY; Hsieh MY; Chen SC; Chuang WL; Lin ZY; Tsai JH
J Med Virol; 1993 Dec; 41(4):296-300. PubMed ID: 7508973
[TBL] [Abstract][Full Text] [Related]
3. An increased risk of hepatitis B virus infection from tattooing in Taiwan.
Ko YC; Lan SJ; Chang PY
Gaoxiong Yi Xue Ke Xue Za Zhi; 1990 May; 6(5):237-43. PubMed ID: 2362302
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of antibodies to hepatitis C virus and association with intravenous drug abuse and tattooing in a national prison in Norway.
Holsen DS; Harthug S; Myrmel H
Eur J Clin Microbiol Infect Dis; 1993 Sep; 12(9):673-6. PubMed ID: 7694850
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of hepatitis virus infection in men who have sex with men aged 18-40 years in Taiwan.
Tseng YT; Sun HY; Chang SY; Wu CH; Liu WC; Wu PY; Lu CL; Hsieh CY; Hung CC
J Formos Med Assoc; 2012 Aug; 111(8):431-8. PubMed ID: 22939661
[TBL] [Abstract][Full Text] [Related]
6. Tattooing in prisons--not such a pretty picture.
Hellard ME; Aitken CK; Hocking JS
Am J Infect Control; 2007 Sep; 35(7):477-80. PubMed ID: 17765561
[TBL] [Abstract][Full Text] [Related]
7. The tattooing paradox: are studies of acute hepatitis adequate to identify routes of transmission of subclinical hepatitis C infection?
Haley RW; Fischer RP
Arch Intern Med; 2003 May; 163(9):1095-8. PubMed ID: 12742809
[TBL] [Abstract][Full Text] [Related]
8. Changing seroepidemiology of hepatitis B, C, and D virus infections in high-risk populations.
Huo TI; Wu JC; Wu SI; Chang AL; Lin SK; Pan CH; Huang YH; Chang FY; Lee SD
J Med Virol; 2004 Jan; 72(1):41-5. PubMed ID: 14635009
[TBL] [Abstract][Full Text] [Related]
9. [Investigations on hepatitis C virus infection among heterosexuals with multiple partners and patients with sexually transmitted diseases].
Ding J
Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Aug; 14(4):231-3. PubMed ID: 7511486
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
[TBL] [Abstract][Full Text] [Related]
11. Acute hepatitis C virus (HCV) infection in chronic carriers of hepatitis B virus (HBV): the impact of underlying active HBV replication on persistence of HCV infection and antibody responses to HCV.
Chu CM; Yeh CT; Sheen IS; Liaw YF
Gut; 2002 Jul; 51(1):95-9. PubMed ID: 12077099
[TBL] [Abstract][Full Text] [Related]
12. Exposure to hepatitis B and C of tattooists in Victoria in 1984.
Thompson SC; Goudey RE; Breschkin AM; Carnie J; Catton M
J Viral Hepat; 1997 Mar; 4(2):135-8. PubMed ID: 9097270
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study.
Simonetti RG; Cammà C; Fiorello F; Cottone M; Rapicetta M; Marino L; Fiorentino G; Craxì A; Ciccaglione A; Giuseppetti R
Ann Intern Med; 1992 Jan; 116(2):97-102. PubMed ID: 1309286
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C-related hepatocellular carcinoma. Prevalence and significance.
Resnick RH; Koff R
Arch Intern Med; 1993 Jul; 153(14):1672-7. PubMed ID: 7687423
[TBL] [Abstract][Full Text] [Related]
16. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
[TBL] [Abstract][Full Text] [Related]
17. Mutual confounding and interactive effects between hepatitis C and hepatitis B viral infections in hepatocellular carcinogenesis: a population-based case-control study in Taiwan.
Sun CA; Farzadegan H; You SL; Lu SN; Wu MH; Wolfe L; Hardy W; Huang GT; Yang PM; Lee H; Chen CJ
Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):173-8. PubMed ID: 8833617
[TBL] [Abstract][Full Text] [Related]
18. Antibodies against hepatitis C virus (anti-HCV) in haemodialysis patients: association with hepatitis B serological markers.
Elisaf M; Tsianos E; Mavridis A; Dardamanis M; Pappas M; Siamopoulos KC
Nephrol Dial Transplant; 1991; 6(7):476-9. PubMed ID: 1717891
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to non-structural hepatitis C virus antigens: a link with liver disease activity?
Gessoni G; Manoni F
Eur J Med; 1992 Sep; 1(5):288-94. PubMed ID: 1285245
[TBL] [Abstract][Full Text] [Related]
20. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan.
Lu SN; Chen TM; Lee CM; Wang JH; Tung HD; Wu JC
J Med Virol; 2003 May; 70(1):74-80. PubMed ID: 12629646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
